GOG ADVL1722 - A Phase 2, multicenter, open-label study to assess safety and preliminary activity of eribulin mesylate in pediatric subjects with relapsed/refractory rhabdomyosarcoma (RMS), nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) and Ewing sarcoma

Project: Research project

Project Details

StatusActive
Effective start/end date12/9/198/31/50

Funding

  • Children's Hospital of Philadelphia
  • Eisai Medical Research Inc.